Consegna Pharma


Consegna Pharma Inc. is a specialty pharmaceutical company dedicated to creating best-in-class long-acting medications. Their mission focuses on developing innovative solutions such as long-acting Naloxone to combat opioid overdoses, aiming to improve overdose reversal treatments and prevent secondary overdoses. The company is located at 2403 Sidney St., Suite 255, Pittsburgh, PA 15203.

Industries

biotechnology
pharmaceutical

Nr. of Employees

small (1-50)

Consegna Pharma

Pittsburgh, Pennsylvania, United States, North America


Products

Long-acting naloxone formulation (12–24 hour release)

A sustained-release naloxone formulation designed to provide 12–24 hours of drug exposure to reduce the need for repeated dosing and help prevent renarcotization after opioid overdose.

CP216

An investigational opioid overdose reversal product that releases an immediate dose of free naloxone followed by a sustained, long-acting release of naloxone over 24 hours to prevent renarcotization from synthetic opioids.

ADSR

Computational Drug Delivery artificial intelligence (AI) based software that calculates formulation specifications using active ingredient, excipient, desired release performance, and end environment data.

Computational Drug Delivery

A proprietary technology platform used to design long-acting injectable medications faster and with reduced regulatory and technical risk.

Expertise Areas

  • Long-acting drug delivery
  • Formulation development
  • Opioid overdose therapeutics
  • Sustained-release product design
  • Show More (1)

Key Technologies

  • Sustained-release / extended-release formulations
  • Long-acting drug delivery systems
  • Controlled-release formulation techniques

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.